Press Releases keyboard_arrow_down
Media Coverage keyboard_arrow_down
Events keyboard_arrow_down

Media Relations

Bob Giuliano, T: +1 610-328-1051 Bob.Giuliano@prplace.biz

 

Customer Contact

Deepak Prakash, T: + 1 773-294-3784 deepak.prakash@eaverydennison.com

Vancive Medical Technologies™ To Exhibit BeneHold™ Absorbent Wound Dressings at European Wound Management Association

Learn More at Booth 10A10

 

CHICAGO – May 13, 2014 – Vancive Medical Technologies™ will exhibit at the 24th Conference of the European Wound Management Association (EWMA), 14-16 May, 2014 at the IFEMA, Madrid in Madrid, Spain.

 

“Exhibiting at EWMA marks the official launch of BeneHold Absorbent Wound Dressings in Europe,” said Colleen Ward, Vice President Global Marketing. “Our products have been shown to provide considerable benefits, especially relative to extended wear time, and we are excited to bring them to market.”

 

On display will be the BeneHold™ Absorbent Wound Dressing range, which features Vancive’s proprietary TASA™, or Thin Absorbent Skin Adhesive™.  At only 0.12 mm in thickness, TASA has the capacity to manage greater quantities of fluid than traditional thin hydrocolloids. Furthermore, the dressings are transparent, allowing for wound site visibility, which, in combination with their high capacity for fluid management and conformability, enables dressings to remain in place for up to seven days.  

 

Vancive will also host an afternoon symposium, “Changing the Game, Not the Dressing: The New Category of “Thin Absorbent” Skin Adhesive”, on May 15:40-16:40 in room N111+N112. The results of recent clinical evaluations will be presented by Jacqui Fletcher, Clinical Strategy Director, Welsh Wound Innovation Centre; Professor Jackie Stephen-Haynes, Birmingham City University; and Rosie Callaghan, Tissue Viability Specialty Nurse.

 

The BeneHold Absorbent Wound Dressing range addresses the needs of light to moderately  exuding chronic and acute wounds. Products and data will be available at the Vancive booth #10A10.

 

BeneHold™ and TASA™  (Thin Absorbent Skin Adhesive™) are trademarks of Avery Dennison Corporation.

 

About Vancive Medical Technologies

Vancive Medical Technologies makes inspired advances that lead to intelligent results. The business uses the most advanced adhesive and material technologies to create products that make healthcare easier for everyone. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. For more information, visit vancive.averydennison.com.

 

About Avery Dennison

Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging materials and solutions. The company’s applications and technologies are an integral part of products used in every major market and industry. With operations in more than 50 countries and 26,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Glendale, California, the company reported sales from continuing operations of $6.1 billion in 2013.  Learn more at www.averydennison.com.

 

###

 

© 2016 Avery Dennison Corporation, All Rights Reserved.

Various trademarks and trade names are used herein and are the property of their respective owners.